GB1297258A - - Google Patents
Info
- Publication number
- GB1297258A GB1297258A GB1297258DA GB1297258A GB 1297258 A GB1297258 A GB 1297258A GB 1297258D A GB1297258D A GB 1297258DA GB 1297258 A GB1297258 A GB 1297258A
- Authority
- GB
- United Kingdom
- Prior art keywords
- silver
- march
- purines
- pyrimidines
- nucleoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NKLZSBHAQMKTDZ-UHFFFAOYSA-N pyrimidine silver Chemical class [Ag].N1=CN=CC=C1 NKLZSBHAQMKTDZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004332 silver Substances 0.000 abstract 2
- 229910052709 silver Inorganic materials 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- QCMREEOJMBTZLE-UHFFFAOYSA-N N1=CN=C2N=CNC2=C1.[Ag] Chemical compound N1=CN=C2N=CNC2=C1.[Ag] QCMREEOJMBTZLE-UHFFFAOYSA-N 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003212 purines Chemical class 0.000 abstract 1
- 150000003378 silver Chemical class 0.000 abstract 1
- -1 silver nucleoside Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1297258 Medicines comprising silver pyrimidines and purines RESEARCH CORP 17 March 1970 [17 March 1969] 12687/70 Heading A5B [Also in Divisions C2 and C3] A therapeutic composition comprises a silver pyrimidine or a silver purine, a silver nucleoside or silver nucleotide or a silver complex of DNA or of RNA and a carrier. A method of use thereof to attack or inhibit the growth of bacteria is also claimed.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80794969A | 1969-03-17 | 1969-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1297258A true GB1297258A (en) | 1972-11-22 |
Family
ID=25197506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1297258D Expired GB1297258A (en) | 1969-03-17 | 1970-03-17 |
Country Status (7)
Country | Link |
---|---|
BE (1) | BE747476A (en) |
CA (1) | CA949562A (en) |
CH (1) | CH547824A (en) |
DE (1) | DE2012717A1 (en) |
FR (1) | FR2034991B1 (en) |
GB (1) | GB1297258A (en) |
NL (1) | NL7003690A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2140689A (en) * | 1983-05-30 | 1984-12-05 | Mitsui Toatsu Chemicals | Treating digestive ulcers using dna |
US5510315A (en) * | 1991-11-08 | 1996-04-23 | Meiji Milk Products Company Limited | Freshness retentive for cut flowers |
US7704530B2 (en) * | 2001-09-14 | 2010-04-27 | Kenji Nakamura | Antimicrobially treated material and methods of preventing coloring thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61186392A (en) * | 1985-02-12 | 1986-08-20 | エンゲルハード・コーポレーシヨン | Gold compound |
CN1466419A (en) | 2000-09-29 | 2004-01-07 | ���Ͽع�����˾ | Stabilized compositions having antibacterial activity |
-
1970
- 1970-03-16 FR FR7009283A patent/FR2034991B1/fr not_active Expired
- 1970-03-16 CA CA077,544A patent/CA949562A/en not_active Expired
- 1970-03-16 NL NL7003690A patent/NL7003690A/xx unknown
- 1970-03-17 GB GB1297258D patent/GB1297258A/en not_active Expired
- 1970-03-17 DE DE19702012717 patent/DE2012717A1/en active Pending
- 1970-03-17 BE BE747476D patent/BE747476A/en unknown
- 1970-03-17 CH CH400170A patent/CH547824A/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2140689A (en) * | 1983-05-30 | 1984-12-05 | Mitsui Toatsu Chemicals | Treating digestive ulcers using dna |
US5510315A (en) * | 1991-11-08 | 1996-04-23 | Meiji Milk Products Company Limited | Freshness retentive for cut flowers |
US7704530B2 (en) * | 2001-09-14 | 2010-04-27 | Kenji Nakamura | Antimicrobially treated material and methods of preventing coloring thereof |
Also Published As
Publication number | Publication date |
---|---|
DE2012717A1 (en) | 1970-10-08 |
FR2034991A1 (en) | 1970-12-18 |
FR2034991B1 (en) | 1974-10-11 |
CH547824A (en) | 1974-04-11 |
CA949562A (en) | 1974-06-18 |
NL7003690A (en) | 1970-09-21 |
BE747476A (en) | 1970-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86863A (en) | STABLE GENE AMPLIFICATION IN CHROMOSOMAL DNA OF PROKARYOTIC MICROORGANISMS | |
ES8700270A1 (en) | Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same. | |
GB1286156A (en) | Sugar composition for topical application | |
IT1238348B (en) | PROCESS FOR THE PREPARATION OF GENETIC BUILDINGS FOR THE EXPRESSION OF THE NERVE GROWTH FACTOR IN EUCARIOT CELLS. | |
GB1297258A (en) | ||
ES8305198A1 (en) | Salt mixture, process for its production and use. | |
CA946308A (en) | Antiviral complex of rna and polysaccharide | |
GB1355516A (en) | Polynucleotides and their production | |
Sparrow et al. | Adenosine triphosphate (ATP) in grassland soil: Its relationship to microbial biomass and activity | |
Williamson et al. | Stimulating effect of amino-acids on the survival at 37° C. of Trypanosoma rhodesiense in a serum-free synthetic medium | |
IT8621422A0 (en) | PROCESS AND PLANT FOR THE CONTINUOUS PRODUCTION OF FRUCTOSE-1,6-DIPHOSPHATE THROUGH THE USE OF IMMOBILIZED BREWER'S YEAST. | |
GB1331933A (en) | Antiviral ribonucleic acids | |
Crkvenjakov et al. | The effect of 5-azacytidine on development, nucleic acid and protein metabolism in sea urchin embryos | |
GB1284150A (en) | Double-stranded ribonucleic acid derivatives | |
FR2073274A1 (en) | 4-mercapto-pyrazolo(3,4-d)-pyrimidines prepn | |
Mamaeva et al. | A study of chromosome content of Friend virus-induced mouse erythroleukemia cells (clone M2) via karyotype reconstruction | |
WO1993013204A3 (en) | Agent for stimulating animal cell division | |
IE33303L (en) | L-asparaginase | |
Kerr et al. | The mechanism of action of interferon: a comparison of ribosomes from interferon-treated and control cells. | |
GB1254744A (en) | Antiviral ribonucleic acid substance | |
GB1237304A (en) | Enzyme produced by cultivating micro-organisms | |
CA890420A (en) | Hydrogenated pyrimidine nucleosides and nucleotides | |
Binkley | Some biochemical changes in penicillin-inhibited Escherichia coli cells | |
JPS53124687A (en) | Preparation of 5'-purine nucleotide | |
USD184322S (en) | Display rack for greeting cards or similar article |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |